Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - 4-methylbenzylidene camphor, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g; ethylhexyl triazone, quantity: 30 mg/g; octocrylene, quantity: 40 mg/g - lotion - excipient ingredients: benzyl alcohol; hydroxyacetophenone; purified water; phenoxyethanol; white beeswax; trolamine; peg-15 cocamine; peg-40 stearate; dl-alpha-tocopheryl acetate; silicon dioxide; hyetellose; carbomer 941; alkyl (c12-15) benzoate; aloe vera - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - 4-methylbenzylidene camphor, quantity: 40 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g; ethylhexyl triazone, quantity: 30 mg/g; octocrylene, quantity: 40 mg/g - lotion - excipient ingredients: benzyl alcohol; hydroxyacetophenone; purified water; phenoxyethanol; white beeswax; trolamine; peg-15 cocamine; peg-40 stearate; dl-alpha-tocopheryl acetate; silicon dioxide; hyetellose; carbomer 941; alkyl (c12-15) benzoate; aloe vera - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - homosalate, quantity: 100 mg/g; octocrylene, quantity: 80 mg/g; butyl methoxydibenzoylmethane, quantity: 40 mg/g; octyl salicylate, quantity: 40 mg/g; ethylhexyl triazone, quantity: 30 mg/g - lotion - excipient ingredients: alkyl (c12-15) benzoate; caprylyl glycol; citric acid; glycerol; octanohydroxamic acid; purified water; trolamine; colloidal anhydrous silica; disodium edetate; xanthan gum; d-alpha-tocopherol; peg-40 stearate; dexpanthenol; cetyl dimeticone; ammonium acryloyldimethyltaurate/vp copolymer; cetostearyl alcohol; ceteareth-20; isostearyl neopentanoate; cyclomethicone - may assist in preventing some skin cancers (sunscreen) ; may reduce the risk of some skin cancers (sunscreen) ; spf 50 plus broad spectrum very high protection sunscreen ; can aid in the prevention of premature skin ageing (sunscreen) ; can aid in the prevention of solar keratosis (sunscreen) ; can aid in the prevention of sunspots (sunscreen)

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - 4-methylbenzylidene camphor,butyl methoxydibenzoylmethane,ethylhexyl triazone,octocrylene -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - 4-methylbenzylidene camphor,butyl methoxydibenzoylmethane,ethylhexyl triazone,octocrylene -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - butyl methoxydibenzoylmethane,ethylhexyl triazone,homosalate,octocrylene,octyl salicylate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun protection apparel pty ltd - butyl methoxydibenzoylmethane,ethylhexyl triazone,homosalate,octocrylene,octyl salicylate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - oxaliplatin, quantity: 200 mg - injection, solution - excipient ingredients: lactose monohydrate; water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - oxaliplatin, quantity: 100 mg - injection, solution - excipient ingredients: water for injections; lactose monohydrate - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer

Australia - English - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - oxaliplatin, quantity: 50 mg - injection, solution - excipient ingredients: lactose monohydrate; water for injections - oxaliplatin, in combination with fluorouracil and folinic acid, is indicated for: - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of the primary tumour; - treatment of advanced colorectal cancer